TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
COSCIENS Biopharma ( (TSE:CSCI) ) just unveiled an update.
On May 2, 2025, COSCIENS Biopharma Inc. announced plans for its upcoming Annual General and Special Meeting of Security Holders, scheduled for June 26, 2025. The company highlighted its strategic decision to sunset certain programs and focus on the development of its core products, which could impact its market positioning and stakeholder interests. The meeting will be held virtually, and the record date for voting is set for May 27, 2025.
More about COSCIENS Biopharma
COSCIENS Biopharma Inc. operates in the biopharmaceutical industry, focusing on the development and commercialization of pharmaceutical and nutraceutical products. The company is known for its patented technologies and value-driving products, including oat-based pipeline products and Macrilen® (macimorelin).
YTD Price Performance: 37.36%
Average Trading Volume: 24,139
Technical Sentiment Signal: Buy
Current Market Cap: $11.83M
For detailed information about CSCI stock, go to TipRanks’ Stock Analysis page.